Brief: Cyclo Therapeutics Receives Positive Opinion From European Medicines Agency On The Agreement Of A Paediatric Investigation Plan For Trappsol Cyclo
09/03/2021 16:50
March 9 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS RECEIVES POSITIVE OPINION FROM THE
PAEDIATRIC
COMMITTEE OF THE EUROPEAN MEDICINES AGENCY ON THE AGREEMENT OF A
PAEDIATRIC INVESTIGATION PLAN FOR TRAPPSOL® CYCLO™
* CYCLO THERAPEUTICS- WITH SUCCESSFUL COMPLETION OF AGREED
PIP,
WOULD BE ELIGIBLE FOR UP TO AN ADDITIONAL TWO YEARS OF MARKETING
EXCLUSIVITY IN EU
Source text for Eikon: ID:nBw37CTNqa
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug